by Cancer Core Europe | Apr 8, 2024 | Cancer Core Europe
CCE’s Imaging Task Force is developing a study to validate the predictive and early response radiomics signatures to atezolizumab in molecularly selected populations with advanced solid tumours. The study is using data from CCE Basket of Baskets (BoB)...
by Cancer Core Europe | Mar 14, 2024 | Meet the People Behind
This time we bring you an insightful interview with Frans Opdam, a medical oncologist and clinical pharmacologist at The Netherlands Cancer Institute (NKI). Frans is renowned for his active role within Cancer Core Europe, where he is the principal investigator in...
by Cancer Core Europe | Mar 12, 2024 | Cancer Core Europe Team, Cancer Core Europe
Cancer Core Europe (CCE) proudly announces the appointment of Karen Barker from the Cancer Research UK (CRUK) Cambridge Centre as their newest representative on the CCE Board of Directors. Karen brings a wealth of experience and expertise to this role, succeeding the...
by Cancer Core Europe | Mar 6, 2024 | Cancer Core Europe
Cancer Core Europe (CCE) proudly stands as a partner in canSERV, an EU-funded initiative under the Horizon Europe program dedicated to advancing cancer research and delivering cutting-edge, interdisciplinary, and tailored oncology...
by Cancer Core Europe | Feb 27, 2024 | CCE Members: DKFZ-NCT, Prevention and Early Detection
The German Cancer Research Center (DKFZ) recently hosted the Symposium on Inherited Susceptibility of Breast Cancer – from Genetic Discovery to Practical Translations, in Heidelberg, Germany, on February 16th. Organized by Rudolf Kaaks and Petra Rössler, the event...
